LncRNA SNHG7 Sponges MiR-216b to Promote Proliferation and Liver Metastasis of Colorectal Cancer Through Upregulating GALNT1

Overview

Journal Cell Death Dis

Specialties Cell Biology
General Medicine

Date 2018 Jun 20

PMID 29915311

Citations 107

Authors

Yujia Shan

Jia Ma

Yue Pan

Jialei Hu

Bing Liu

Li Jia

Affiliations

Soon will be listed here.

Abstract

Accumulating evidence suggests long noncoding RNAs (lncRNAs) play an important role in cancer progression. However, the function of lncRNA SNHG7 in colorectal cancer (CRC) remains unclear. In this study, SNHG7 expression was significantly upregulated in CRC tissues, especially in aggressive cases. In accordance, high level of SNHG7 was observed in CRC cell lines compared to normal colon cells. Furthermore, SNHG7 overexpression promoted the proliferation, migration, and invasion of CRC cell lines, while SNHG7 depletion inhibited invasion and cell viability in vitro. Mechanistically, knockdown of SNHG7 inhibited GALNT1 and EMT markers (E-cadherin and Vimentin). Importantly, SNHG7 directly interacted with miR-216b and downregulation of miR-216b reversed efficiently the suppression of GALNT1 induced by SNHG7 siRNA. Moreover, overexpression of SNHG7 significantly enhanced the tumorigenesis and liver metastasis of SW480 cells in vivo. SNHG7 positively regulated GALNT1 level through sponging miR-216b, and played an oncogenic role in CRC progression. Together, our study elucidated the role of SNHG7 as an miRNA sponge in CRC, and shed new light on lncRNA-directed diagnostics and therapeutics in CRC.

Citing Articles

Biofluid-Derived Exosomal LncRNAs: Their Potential in Obesity and Related Comorbidities.

Ngowi E, Lu T, Liu Q, Xie X, Wang N, Luo L Biology (Basel). 2025; 13(12.

PMID: 39765643 PMC: 11673191. DOI: 10.3390/biology13120976.

Dong Y, He Y, Geng Y, Wei M, Zhou X, Lian J Cancer Cell Int. 2024; 24(1):328.

PMID: 39342235 PMC: 11439232. DOI: 10.1186/s12935-024-03503-1.

METTL3-Regulated lncRNA SNHG7 Drives MNNG-Induced Epithelial-Mesenchymal Transition in Gastric Precancerous Lesions.

Jian J, Feng Y, Wang R, Li C, Zhang L, Ruan Y Toxics. 2024; 12(8).

PMID: 39195675 PMC: 11360688. DOI: 10.3390/toxics12080573.

Identification of ASMTL-AS1 and LINC02604 lncRNAs as novel biomarkers for diagnosis of colorectal cancer.

Shakeri F, Mohamadynejad P, Moghanibashi M Int J Colorectal Dis. 2024; 39(1):112.

PMID: 39028420 PMC: 11271384. DOI: 10.1007/s00384-024-04692-x.

LncRNA LINC00466 Promotes the Progression of Breast Cancer miR-4731-5p/EPHA2 Pathway.

Han X, Shi F, Guo S, Li Y, Wang H, Song C Curr Pharm Biotechnol. 2024; 26(1):120-131.

PMID: 38726776 DOI: 10.2174/0113892010290582240419051056.

References

Cheng S, Huang Liu R, Sheu J, Chen S, Sinchaikul S, Tsay G . Toxicogenomics of kojic acid on gene expression profiling of a375 human malignant melanoma cells. Biol Pharm Bull. 2006; 29(4):655-69. DOI: 10.1248/bpb.29.655. View

Zhou X, Gao Q, Wang J, Zhang X, Liu K, Duan Z . Linc-RNA-RoR acts as a "sponge" against mediation of the differentiation of endometrial cancer stem cells by microRNA-145. Gynecol Oncol. 2014; 133(2):333-9. DOI: 10.1016/j.ygyno.2014.02.033. View

Milde-Langosch K, Schutze D, Oliveira-Ferrer L, Wikman H, Muller V, Lebok P . Relevance of βGal-βGalNAc-containing glycans and the enzymes involved in their synthesis for invasion and survival in breast cancer patients. Breast Cancer Res Treat. 2015; 151(3):515-28. DOI: 10.1007/s10549-015-3425-0. View

Stiegelbauer V, Vychytilova-Faltejskova P, Karbiener M, Pehserl A, Reicher A, Resel M . miR-196b-5p Regulates Colorectal Cancer Cell Migration and Metastases through Interaction with HOXB7 and GALNT5. Clin Cancer Res. 2017; 23(17):5255-5266. DOI: 10.1158/1078-0432.CCR-17-0023. View

Chen Z, Gao S, Wang D, Song D, Feng Y . Colorectal cancer cells are resistant to anti-EGFR monoclonal antibody through adapted autophagy. Am J Transl Res. 2016; 8(2):1190-6. PMC: 4846962. View

Dyrskjot L, Ostenfeld M, Bramsen J, Silahtaroglu A, Lamy P, Ramanathan R . Genomic profiling of microRNAs in bladder cancer: miR-129 is associated with poor outcome and promotes cell death in vitro. Cancer Res. 2009; 69(11):4851-60. DOI: 10.1158/0008-5472.CAN-08-4043. View

Yuan P, Cao W, Zang Q, Li G, Guo X, Fan J . The HIF-2α-MALAT1-miR-216b axis regulates multi-drug resistance of hepatocellular carcinoma cells via modulating autophagy. Biochem Biophys Res Commun. 2016; 478(3):1067-73. DOI: 10.1016/j.bbrc.2016.08.065. View

Qu J, Li M, Zhong W, Hu C . Competing endogenous RNA in cancer: a new pattern of gene expression regulation. Int J Clin Exp Med. 2016; 8(10):17110-6. PMC: 4694204. View

Zhou M, Zhong L, Xu W, Sun Y, Zhang Z, Zhao H . Discovery of potential prognostic long non-coding RNA biomarkers for predicting the risk of tumor recurrence of breast cancer patients. Sci Rep. 2016; 6:31038. PMC: 4977495. DOI: 10.1038/srep31038. View

10.

Tuck A, Tollervey D . RNA in pieces. Trends Genet. 2011; 27(10):422-32. DOI: 10.1016/j.tig.2011.06.001. View

11.

Chen W, Zheng R, Zhang S, Zhao P, Zeng H, Zou X . Report of cancer incidence and mortality in China, 2010. Ann Transl Med. 2014; 2(7):61. PMC: 4202458. DOI: 10.3978/j.issn.2305-5839.2014.04.05. View

12.

. Finishing the euchromatic sequence of the human genome. Nature. 2004; 431(7011):931-45. DOI: 10.1038/nature03001. View

13.

Han D, Wang M, Ma N, Xu Y, Jiang Y, Gao X . Long noncoding RNAs: novel players in colorectal cancer. Cancer Lett. 2015; 361(1):13-21. DOI: 10.1016/j.canlet.2015.03.002. View

14.

Taniuchi K, Cerny R, Tanouchi A, Kohno K, Kotani N, Honke K . Overexpression of GalNAc-transferase GalNAc-T3 promotes pancreatic cancer cell growth. Oncogene. 2011; 30(49):4843-54. PMC: 3373266. DOI: 10.1038/onc.2011.194. View

15.

Cassidy S, Syed B . Colorectal cancer drugs market. Nat Rev Drug Discov. 2017; 16(8):525-526. DOI: 10.1038/nrd.2017.59. View

16.

Sun M, Wang X, Tu C, Wang S, Qu J, Xiao S . microRNA-216b inhibits cell proliferation and migration in human melanoma by targeting FOXM1 in vitro and in vivo. Cell Biol Int. 2017; 41(12):1272-1282. DOI: 10.1002/cbin.10754. View

17.

Quinn L, Finn S, Cuffe S, Gray S . Non-coding RNA repertoires in malignant pleural mesothelioma. Lung Cancer. 2016; 90(3):417-26. DOI: 10.1016/j.lungcan.2015.11.002. View

18.

Huang M, Hu R, Chou C, Hsu C, Liu Y, Huang J . Knockdown of GALNT1 suppresses malignant phenotype of hepatocellular carcinoma by suppressing EGFR signaling. Oncotarget. 2015; 6(8):5650-65. PMC: 4467392. DOI: 10.18632/oncotarget.3117. View

19.

Wu Y, Liu C, Hu R, Huang M, Lee J, Chen C . Mucin glycosylating enzyme GALNT2 regulates the malignant character of hepatocellular carcinoma by modifying the EGF receptor. Cancer Res. 2011; 71(23):7270-9. DOI: 10.1158/0008-5472.CAN-11-1161. View

20.

Bennett E, Mandel U, Clausen H, Gerken T, Fritz T, Tabak L . Control of mucin-type O-glycosylation: a classification of the polypeptide GalNAc-transferase gene family. Glycobiology. 2011; 22(6):736-56. PMC: 3409716. DOI: 10.1093/glycob/cwr182. View